These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8169419)

  • 21. GM1 antibody in Guillain-Barre syndrome after Campylobacter jejuni infection.
    Tang J; Yuan J; Hao H
    Chin Med J (Engl); 1995 Apr; 108(4):262-4. PubMed ID: 7789212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Campylobacter jejuni isolates from Japanese patients with Guillain-Barré syndrome.
    Saida T; Kuroki S; Hao Q; Nishimura M; Nukina M; Obayashi H
    J Infect Dis; 1997 Dec; 176 Suppl 2():S129-34. PubMed ID: 9396696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guillain-Barré syndrome associated with Campylobacter jejuni infection in England, 2000-2001.
    Tam CC; Rodrigues LC; O'Brien SJ
    Clin Infect Dis; 2003 Jul; 37(2):307-10. PubMed ID: 12856224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does Campylobacter jejuni infection elicit axonal or demyelinating Guillain-Barré syndrome, or both?
    Kuwabara S
    J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):238. PubMed ID: 21325023
    [No Abstract]   [Full Text] [Related]  

  • 25. Campylobacter jejuni Infection and treatment for Guillain-Barré Syndrome.
    Jacobs BC; Schmitz PI; van der Meche FG
    N Engl J Med; 1996 Jul; 335(3):208-9. PubMed ID: 8657230
    [No Abstract]   [Full Text] [Related]  

  • 26. The Guillain-Barré syndrome at 75: the Campylobacter connection.
    Griffin JW; Ho TW
    Ann Neurol; 1993 Aug; 34(2):125-7. PubMed ID: 8338335
    [No Abstract]   [Full Text] [Related]  

  • 27. [Etiological mechanism and treatment of Guillain-Barre syndrome-- Campylobacter jejuni enteritis and the development of anti-ganglioside antibody preceding the syndrome].
    Yuki N
    Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):612-6. PubMed ID: 9627467
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of infection due to Campylobacter jejuni in the initiation of Guillain-Barré syndrome.
    Mishu B; Blaser MJ
    Clin Infect Dis; 1993 Jul; 17(1):104-8. PubMed ID: 8353228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The changing concepts of Guillain-Barré syndrome.
    Bolton CF
    N Engl J Med; 1995 Nov; 333(21):1415-7. PubMed ID: 7477125
    [No Abstract]   [Full Text] [Related]  

  • 30. Campylobacter jejuni infection and Guillain-Barré syndrome: a case-control study. Emilia-Romagna Study Group on Clinical and Epidemiological problems in neurology.
    Guarino M; Casmiro M; D'Alessandro R
    Neuroepidemiology; 1998; 17(6):296-302. PubMed ID: 9890808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guillain-Barré syndrome and Campylobacter infection.
    Isaäcson M
    J Travel Med; 1998 Sep; 5(3):160. PubMed ID: 9882164
    [No Abstract]   [Full Text] [Related]  

  • 32. Guillain-Barré syndrome associated with Campylobacter infection.
    Kuroki S; Haruta T; Yoshioka M; Kobayashi Y; Nukina M; Nakanishi H
    Pediatr Infect Dis J; 1991 Feb; 10(2):149-51. PubMed ID: 2062607
    [No Abstract]   [Full Text] [Related]  

  • 33. Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh.
    Islam Z; Jacobs BC; van Belkum A; Mohammad QD; Islam MB; Herbrink P; Diorditsa S; Luby SP; Talukder KA; Endtz HP
    Neurology; 2010 Feb; 74(7):581-7. PubMed ID: 20157160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and epidemiologic features of Guillain-Barré syndrome.
    Hughes RA; Rees JH
    J Infect Dis; 1997 Dec; 176 Suppl 2():S92-8. PubMed ID: 9396689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A descriptive study of Guillain-Barré syndrome in high and low Campylobacter jejuni incidence regions of Michigan: 1992-1999.
    Church Potter R; Kaneene JB
    Neuroepidemiology; 2003; 22(4):245-8. PubMed ID: 12792145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Guillain-Barré syndrome].
    Yuki N
    Nihon Rinsho; 1994 Nov; 52(11):2952-8. PubMed ID: 7996693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Guillain-Barré syndrome and infection].
    Saida T; Hao Q; Obayashi H; Nishimura K; Ozawa K; Saida K
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1378-9. PubMed ID: 8752403
    [No Abstract]   [Full Text] [Related]  

  • 38. Epidemiologic and clinical features of Campylobacter jejuni infections.
    Blaser MJ
    J Infect Dis; 1997 Dec; 176 Suppl 2():S103-5. PubMed ID: 9396691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Five cases of Campylobacter jejuni enteritis accompanied with Guillain-Barré syndrome].
    Yuan JM; Tang J; Hao HJ
    Zhonghua Nei Ke Za Zhi; 1993 Jun; 32(6):375-7. PubMed ID: 8269767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Guillain-Barré syndrome associated with anti-GalNAc-GD1a antibody subsequent to Campylobacter jejuni enteritis].
    Tsuda N; Negoro K; Morimatsu M; Saito K; Yuki N
    Rinsho Shinkeigaku; 1995 Feb; 35(2):208-10. PubMed ID: 7781242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.